{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:38:54Z","timestamp":1782301134553,"version":"3.54.5"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,14]]},"DOI":"10.7759\/cureus.41883","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T15:51:51Z","timestamp":1689349911000},"source":"Crossref","is-referenced-by-count":7,"title":["Autoimmune Dysphagia Related to Rheumatologic Disorders: A Focused Review on Diagnosis and Treatment"],"prefix":"10.7759","author":[{"given":"Mohammed Rifat","family":"Shaik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishat Anjum","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Mikdashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04495-2","article-title":"Dysphagia in neurological diseases: a literature review","volume":"41","author":"Panebianco M","year":"2020","unstructured":"Panebianco M, Marchese-Ragona R, Masiero S, Restivo DA. Dysphagia in neurological diseases: a literature review. Neurol Sci. 2020, 41:3067-73. 10.1007\/s10072-020-04495-2","journal-title":"Neurol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.199","article-title":"Oropharyngeal dysphagia: manifestations and diagnosis","volume":"13","author":"Rommel N","year":"2016","unstructured":"Rommel N, Hamdy S. Oropharyngeal dysphagia: manifestations and diagnosis. Nat Rev Gastroenterol Hepatol. 2016, 13:49-59. 10.1038\/nrgastro.2015.199","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2007.02.060045","article-title":"The prevalence of dysphagia in primary care patients: a HamesNet Research Network study","volume":"20","author":"Wilkins T","year":"2007","unstructured":"Wilkins T, Gillies RA, Thomas AM, Wagner PJ. The prevalence of dysphagia in primary care patients: a HamesNet Research Network study. J Am Board Fam Med. 2007, 20:144-50. 10.3122\/jabfm.2007.02.060045","journal-title":"J Am Board Fam Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-021-10338-9","article-title":"Autoimmune neurogenic dysphagia","volume":"37","author":"Stathopoulos P","year":"2022","unstructured":"Stathopoulos P, Dalakas MC. Autoimmune neurogenic dysphagia. Dysphagia. 2022, 37:473-87. 10.1007\/s00455-021-10338-9","journal-title":"Dysphagia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S97481","article-title":"Oropharyngeal dysphagia in older persons - from pathophysiology to adequate intervention: a review and summary of an international expert meeting","volume":"11","author":"Wirth R","year":"2016","unstructured":"Wirth R, Dziewas R, Beck AM, et al.. Oropharyngeal dysphagia in older persons - from pathophysiology to adequate intervention: a review and summary of an international expert meeting. Clin Interv Aging. 2016, 11:189-208. 10.2147\/CIA.S97481","journal-title":"Clin Interv Aging"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072150","article-title":"The impact of dysphagia in myositis: a systematic review and meta-analysis","volume":"9","author":"Labeit B","year":"2020","unstructured":"Labeit B, Pawlitzki M, Ruck T, et al.. The impact of dysphagia in myositis: a systematic review and meta-analysis. J Clin Med. 2020, 9:10.3390\/jcm9072150","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/1947-2714.120788","article-title":"Malignancy and idiopathic inflammatory myopathies","volume":"5","author":"Ungprasert P","year":"2013","unstructured":"Ungprasert P, Bethina NK, Jones CH. Malignancy and idiopathic inflammatory myopathies. N Am J Med Sci. 2013, 5:569-72. 10.4103\/1947-2714.120788","journal-title":"N Am J Med Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai K","year":"2018","unstructured":"Mariampillai K, Granger B, Amelin D, et al.. Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies. JAMA Neurol. 2018, 75:1528-37. 10.1001\/jamaneurol.2018.2598","journal-title":"JAMA Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000740","article-title":"Classification of idiopathic inflammatory myopathies: pathology perspectives","volume":"32","author":"Tanboon J","year":"2019","unstructured":"Tanboon J, Nishino I. Classification of idiopathic inflammatory myopathies: pathology perspectives. Curr Opin Neurol. 2019, 32:704-14. 10.1097\/WCO.0000000000000740","journal-title":"Curr Opin Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0726-4","article-title":"New myositis classification criteria-what we have learned since Bohan and Peter","volume":"20","author":"Leclair V","year":"2018","unstructured":"Leclair V, Lundberg IE. New myositis classification criteria-what we have learned since Bohan and Peter. Curr Rheumatol Rep. 2018, 20:18. 10.1007\/s11926-018-0726-4","journal-title":"Curr Rheumatol Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2018.41","article-title":"Classification of myositis","volume":"14","author":"Lundberg IE","year":"2018","unstructured":"Lundberg IE, de Visser M, Werth VP. Classification of myositis. Nat Rev Rheumatol. 2018, 14:269-78. 10.1038\/nrrheum.2018.41","journal-title":"Nat Rev Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211868","article-title":"The EuroMyositis registry: an international collaborative tool to facilitate myositis research","volume":"77","author":"Lilleker JB","year":"2018","unstructured":"Lilleker JB, Vencovsky J, Wang G, et al.. The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis. 2018, 77:30-9. 10.1136\/annrheumdis-2017-211868","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-019-0021-5","article-title":"Safety and clinical impact of FEES - results of the FEES-registry","volume":"1","author":"Dziewas R","year":"2019","unstructured":"Dziewas R, Auf dem Brinke M, Birkmann U, et al.. Safety and clinical impact of FEES - results of the FEES-registry. Neurol Res Pract. 2019, 1:16. 10.1186\/s42466-019-0021-5","journal-title":"Neurol Res Pract"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2020.11.001","article-title":"Dysphagia in adult myopathies","volume":"31","author":"Argov Z","year":"2021","unstructured":"Argov Z, de Visser M. Dysphagia in adult myopathies. Neuromuscul Disord. 2021, 31:5-20. 10.1016\/j.nmd.2020.11.001","journal-title":"Neuromuscul Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081x(88)90046-6","article-title":"A rheumatologist's view of polymyositis\/dermatomyositis: extracutaneous and extramuscular involvement and overlap syndromes","volume":"6","author":"Romans B","year":"1988","unstructured":"Romans B, Cohen S. A rheumatologist's view of polymyositis\/dermatomyositis: extracutaneous and extramuscular involvement and overlap syndromes. Clin Dermatol. 1988, 6:15-22. 10.1016\/0738-081x(88)90046-6","journal-title":"Clin Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00739","article-title":"Dysphagia as isolated manifestation of Jo-1 associated myositis?","volume":"10","author":"Labeit B","year":"2019","unstructured":"Labeit B, Muhle P, Suntrup-Krueger S, Ahring S, Ruck T, Dziewas R, Warnecke T. Dysphagia as isolated manifestation of Jo-1 associated myositis?. Front Neurol. 2019, 10:739. 10.3389\/fneur.2019.00739","journal-title":"Front Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5056\/jnm16028","article-title":"Failed deglutitive upper esophageal sphincter relaxation is a risk factor for aspiration in stroke patients with oropharyngeal dysphagia","volume":"23","author":"Lee T","year":"2017","unstructured":"Lee T, Park JH, Sohn C, Yoon KJ, Lee YT, Park JH, Jung IS. Failed deglutitive upper esophageal sphincter relaxation is a risk factor for aspiration in stroke patients with oropharyngeal dysphagia. J Neurogastroenterol Motil. 2017, 23:34-40. 10.5056\/jnm16028","journal-title":"J Neurogastroenterol Motil"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00334-4","article-title":"Management of upper esophageal sphincter disorders: indications and complications of myotomy","volume":"108","author":"Kelly JH","year":"2000","unstructured":"Kelly JH. Management of upper esophageal sphincter disorders: indications and complications of myotomy. Am J Med. 2000, 108:43-6. 10.1016\/S0002-9343(99)00334-4","journal-title":"Am J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26996","article-title":"Myopathies featuring early or prominent dysphagia","volume":"62","author":"Triplett JD","year":"2020","unstructured":"Triplett JD, Pinto MV, Hosfield EA, Milone M, Liewluck T. Myopathies featuring early or prominent dysphagia. Muscle Nerve. 2020, 62:344-50. 10.1002\/mus.26996","journal-title":"Muscle Nerve"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5229-9","article-title":"Detecting dysphagia in inclusion body myositis","volume":"256","author":"Cox FM","year":"2009","unstructured":"Cox FM, Verschuuren JJ, Verbist BM, Niks EH, Wintzen AR, Badrising UA. Detecting dysphagia in inclusion body myositis. J Neurol. 2009, 256:2009-13. 10.1007\/s00415-009-5229-9","journal-title":"J Neurol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.09.014","article-title":"Five-year history of dysphagia as a sole initial symptom in inclusion body myositis","volume":"381","author":"Shibata S","year":"2017","unstructured":"Shibata S, Izumi R, Hara T, et al.. Five-year history of dysphagia as a sole initial symptom in inclusion body myositis. J Neurol Sci. 2017, 381:325-7. 10.1016\/j.jns.2017.09.014","journal-title":"J Neurol Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S198031","article-title":"Dysphagia in patients with sporadic inclusion body myositis: management challenges","volume":"12","author":"Mohannak N","year":"2019","unstructured":"Mohannak N, Pattison G, Hird K, Needham M. Dysphagia in patients with sporadic inclusion body myositis: management challenges. Int J Gen Med. 2019, 12:465-74. 10.2147\/IJGM.S198031","journal-title":"Int J Gen Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051146","article-title":"Anti-CN1A antibodies are associated with more severe dysphagia in sporadic inclusion body myositis","volume":"10","author":"Lucchini M","year":"2021","unstructured":"Lucchini M, Maggi L, Pegoraro E, et al.. Anti-CN1A antibodies are associated with more severe dysphagia in sporadic inclusion body myositis. Cells. 2021, 10:10.3390\/cells10051146","journal-title":"Cells"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-011-0814-y","article-title":"A dysphagia study in patients with sporadic inclusion body myositis (s-IBM)","volume":"33","author":"Murata KY","year":"2012","unstructured":"Murata KY, Kouda K, Tajima F, Kondo T. A dysphagia study in patients with sporadic inclusion body myositis (s-IBM). Neurol Sci. 2012, 33:765-70. 10.1007\/s10072-011-0814-y","journal-title":"Neurol Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1506827","article-title":"Inflammatory muscle diseases","volume":"373","author":"Young P","year":"2015","unstructured":"Young P, Finn BC, Reisin R. Inflammatory muscle diseases. N Engl J Med. 2015, 373:393. 10.1056\/NEJMc1506827","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-012-0249-3","article-title":"Morbidity and mortality in adult polymyositis and dermatomyositis","volume":"14","author":"Marie I","year":"2012","unstructured":"Marie I. Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep. 2012, 14:275-85. 10.1007\/s11926-012-0249-3","journal-title":"Curr Rheumatol Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-022-05372-z","article-title":"Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort","volume":"23","author":"Yang H","year":"2022","unstructured":"Yang H, Tian X, Zhang L, et al.. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort. BMC Musculoskelet Disord. 2022, 23:425. 10.1186\/s12891-022-05372-z","journal-title":"BMC Musculoskelet Disord"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.36185\/2532-1900-032","article-title":"Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications","volume":"39","author":"Dalakas MC","year":"2020","unstructured":"Dalakas MC. Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications. Acta Myol. 2020, 39:289-301. 10.36185\/2532-1900-032","journal-title":"Acta Myol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken029","article-title":"Dysphagia and other manifestations of oesophageal involvement in the musculoskeletal diseases","volume":"47","author":"Sheehan NJ","year":"2008","unstructured":"Sheehan NJ. Dysphagia and other manifestations of oesophageal involvement in the musculoskeletal diseases. Rheumatology (Oxford). 2008, 47:746-52. 10.1093\/rheumatology\/ken029","journal-title":"Rheumatology (Oxford)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154746","article-title":"Oropharyngeal dysphagia in dermatomyositis: associations with clinical and laboratory features including autoantibodies","volume":"11","author":"Mugii N","year":"2016","unstructured":"Mugii N, Hasegawa M, Matsushita T, et al.. Oropharyngeal dysphagia in dermatomyositis: associations with clinical and laboratory features including autoantibodies. PLoS One. 2016, 11:e0154746. 10.1371\/journal.pone.0154746","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbr.2015.08.011","article-title":"What rheumatologists should know about orofacial manifestations of autoimmune rheumatic diseases","author":"Abr\u00e3o AL","year":"2016","unstructured":"Abr\u00e3o AL, Santana CM, Bezerra AC, Amorim RF, Silva MB, Mota LM, Falc\u00e3o DP. What rheumatologists should know about orofacial manifestations of autoimmune rheumatic diseases. Rev Bras Reumatol. 2016, 10.1016\/j.rbr.2015.08.011","journal-title":"Rev Bras Reumatol"},{"key":"ref32","article-title":"New insights into antisynthetase syndrome","volume":"11","author":"Cojocaru M","year":"2016","unstructured":"Cojocaru M, Cojocaru IM, Chicos B. New insights into antisynthetase syndrome. Maedica (Bucur). 2016, 11:130-5.","journal-title":"Maedica (Bucur)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.0934","article-title":"Skeletal muscle involvement in antisynthetase syndrome","volume":"74","author":"Noguchi E","year":"2017","unstructured":"Noguchi E, Uruha A, Suzuki S, et al.. Skeletal muscle involvement in antisynthetase syndrome. JAMA Neurol. 2017, 74:992-9. 10.1001\/jamaneurol.2017.0934","journal-title":"JAMA Neurol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i31.5201","article-title":"Dysphagia, reflux and related sequelae due to altered physiology in scleroderma","volume":"27","author":"Kadakuntla A","year":"2021","unstructured":"Kadakuntla A, Juneja A, Sattler S, et al.. Dysphagia, reflux and related sequelae due to altered physiology in scleroderma. World J Gastroenterol. 2021, 27:5201-18. 10.3748\/wjg.v27.i31.5201","journal-title":"World J Gastroenterol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2018.0228","article-title":"Evaluation and management of esophageal manifestations in systemic sclerosis","volume":"31","author":"Denaxas K","year":"2018","unstructured":"Denaxas K, Ladas SD, Karamanolis GP. Evaluation and management of esophageal manifestations in systemic sclerosis. Ann Gastroenterol. 2018, 31:165-70. 10.20524\/aog.2018.0228","journal-title":"Ann Gastroenterol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-007-0018-8","article-title":"Gastrointestinal manifestations of systemic sclerosis","volume":"53","author":"Domsic R","year":"2008","unstructured":"Domsic R, Fasanella K, Bielefeldt K. Gastrointestinal manifestations of systemic sclerosis. Dig Dis Sci. 2008, 53:1163-74. 10.1007\/s10620-007-0018-8","journal-title":"Dig Dis Sci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2017.70467","article-title":"Systemic sclerosis and the gastrointestinal tract","volume":"12","author":"Walecka I","year":"2017","unstructured":"Walecka I. Systemic sclerosis and the gastrointestinal tract. Prz Gastroenterol. 2017, 12:163-8. 10.5114\/pg.2017.70467","journal-title":"Prz Gastroenterol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2021.04.014","article-title":"Multimodality imaging of the gastrointestinal manifestations of scleroderma","volume":"76","author":"Delaney FT","year":"2021","unstructured":"Delaney FT, Fenlon HM, Buckley B, Welaratne I, Cronin CG. Multimodality imaging of the gastrointestinal manifestations of scleroderma. Clin Radiol. 2021, 76:640-9. 10.1016\/j.crad.2021.04.014","journal-title":"Clin Radiol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000225549.19127.90","article-title":"Esophageal disease in scleroderma","volume":"40","author":"Ebert EC","year":"2006","unstructured":"Ebert EC. Esophageal disease in scleroderma. J Clin Gastroenterol. 2006, 40:769-75. 10.1097\/01.mcg.0000225549.19127.90","journal-title":"J Clin Gastroenterol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023677","article-title":"Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis (\"ProDERM Study\")","volume":"100","author":"Aggarwal R","year":"2021","unstructured":"Aggarwal R, Charles-Schoeman C, Schessl J, Dimachkie MM, Beckmann I, Levine T. Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis (\"ProDERM Study\"). Medicine (Baltimore). 2021, 100:e23677. 10.1097\/MD.0000000000023677","journal-title":"Medicine (Baltimore)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2017.09.010","article-title":"Gastrointestinal and hepatic disease in Sjogren syndrome","volume":"44","author":"Popov Y","year":"2018","unstructured":"Popov Y, Salomon-Escoto K. Gastrointestinal and hepatic disease in Sjogren syndrome. Rheum Dis Clin North Am. 2018, 44:143-51. 10.1016\/j.rdc.2017.09.010","journal-title":"Rheum Dis Clin North Am"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1080\/03009740701607638","article-title":"Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sj\u00f6gren's syndrome","volume":"36","author":"Mandl T","year":"2007","unstructured":"Mandl T, Ekberg O, Wollmer P, Manthorpe R, Jacobsson LT. Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sj\u00f6gren's syndrome. Scand J Rheumatol. 2007, 36:394-401. 10.1080\/03009740701607638","journal-title":"Scand J Rheumatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3182329d9c","article-title":"Gastrointestinal and hepatic manifestations of Sjogren syndrome","volume":"46","author":"Ebert EC","year":"2012","unstructured":"Ebert EC. Gastrointestinal and hepatic manifestations of Sjogren syndrome. J Clin Gastroenterol. 2012, 46:25-30. 10.1097\/MCG.0b013e3182329d9c","journal-title":"J Clin Gastroenterol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s00455-015-9657-7","article-title":"Swallowing disorders in Sj\u00f6gren\u2019s syndrome: prevalence, risk factors, and effects on quality of life","volume":"31","author":"Pierce JL","year":"2016","unstructured":"Pierce JL, Tanner K, Merrill RM, Miller KL, Kendall KA, Roy N. Swallowing disorders in Sj\u00f6gren\u2019s syndrome: prevalence, risk factors, and effects on quality of life. Dysphagia. 2016, 31:49-59. 10.1007\/s00455-015-9657-7","journal-title":"Dysphagia"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.14424","article-title":"New developments in esophageal function testing and esophageal manifestations of connective tissue disorders","volume":"1481","author":"Akiyama J","year":"2020","unstructured":"Akiyama J, Sumida J, Nakagawa K, et al.. New developments in esophageal function testing and esophageal manifestations of connective tissue disorders. Ann N Y Acad Sci. 2020, 1481:170-81. 10.1111\/nyas.14424","journal-title":"Ann N Y Acad Sci"},{"key":"ref46","article-title":"Systemic diseases and syndromes [Article in French]","author":"Gabay C","year":"1985","unstructured":"Gabay C. Systemic diseases and syndromes [Article in French]. Kahn M-F, Peltier A-P, Meyer O, Piette J-C (ed): M\u00e9decine-Sciences Flammarion, Paris; 1985."},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9692030","article-title":"Clinical and immunological profile of mixed connective tissue disease and a comparison of four diagnostic criteria","volume":"2020","author":"John KJ","year":"2020","unstructured":"John KJ, Sadiq M, George T, Gunasekaran K, Francis N, Rajadurai E, Sudarsanam TD. Clinical and immunological profile of mixed connective tissue disease and a comparison of four diagnostic criteria. Int J Rheumatol. 2020, 2020:9692030. 10.1155\/2020\/9692030","journal-title":"Int J Rheumatol"},{"key":"ref48","article-title":"Esophageal disorders in mixed connective tissue diseases","volume":"9","author":"Nica A","year":"2016","unstructured":"Nica A, Alexa L, Ionescu A, Andronic O, P\u0103duraru D. Esophageal disorders in mixed connective tissue diseases. J Med Life. 2016, 9:141-3.","journal-title":"J Med Life"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(12)90338-8","article-title":"Gastrointestinal manifestations of mixed connective tissue disease","volume":"98","author":"Marshall JB","year":"1990","unstructured":"Marshall JB, Kretschmar JM, Gerhardt DC, et al.. Gastrointestinal manifestations of mixed connective tissue disease. Gastroenterology. 1990, 98:1232-8. 10.1016\/s0016-5085(12)90338-8","journal-title":"Gastroenterology"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1007\/BF01297214","article-title":"Esophageal dysfunction in patients with mixed connective tissue diseases and systemic lupus erythematosus","volume":"27","author":"Gutierrez F","year":"1982","unstructured":"Gutierrez F, Valenzuela JE, Ehresmann GR, Quismorio FP, Kitridou RC. Esophageal dysfunction in patients with mixed connective tissue diseases and systemic lupus erythematosus. Dig Dis Sci. 1982, 27:592-7. 10.1007\/BF01297214","journal-title":"Dig Dis Sci"},{"key":"ref51","article-title":"Manifestations of systemic lupus erythematosus","volume":"6","author":"Cojocaru M","year":"2011","unstructured":"Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD. Manifestations of systemic lupus erythematosus. Maedica (Bucur). 2011, 6:330-6.","journal-title":"Maedica (Bucur)"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.10.917","article-title":"A review of gastrointestinal manifestations of systemic lupus erythematosus","volume":"38","author":"Sultan SM","year":"1999","unstructured":"Sultan SM, Ioannou Y, Isenberg DA. A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology (Oxford). 1999, 38:917-32. 10.1093\/rheumatology\/38.10.917","journal-title":"Rheumatology (Oxford)"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31820f81b8","article-title":"Gastrointestinal and hepatic manifestations of systemic lupus erythematosus","volume":"45","author":"Ebert EC","year":"2011","unstructured":"Ebert EC, Hagspiel KD. Gastrointestinal and hepatic manifestations of systemic lupus erythematosus. J Clin Gastroenterol. 2011, 45:436-41. 10.1097\/MCG.0b013e31820f81b8","journal-title":"J Clin Gastroenterol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02614-8","article-title":"The prevalence of oral mucosal lesions and related factors in systemic lupus erythematosus patients","volume":"23","author":"Kudsi M","year":"2021","unstructured":"Kudsi M, Nahas LD, Alsawah R, Hamsho A, Omar A. The prevalence of oral mucosal lesions and related factors in systemic lupus erythematosus patients. Arthritis Res Ther. 2021, 23:229. 10.1186\/s13075-021-02614-8","journal-title":"Arthritis Res Ther"},{"key":"ref55","article-title":"Antibodies to hn-RNP protein A1 in systemic lupus erythematosus: clinical association with Raynaud's phenomenon and esophageal dysmotility","volume":"10","author":"Montecucco C","year":"1992","unstructured":"Montecucco C, Caporali R, Cobianchi F, Negri C, Astaldi-Ricotti GC. Antibodies to hn-RNP protein A1 in systemic lupus erythematosus: clinical association with Raynaud's phenomenon and esophageal dysmotility. Clin Exp Rheumatol. 1992, 10:223-7.","journal-title":"Clin Exp Rheumatol"},{"key":"ref56","article-title":"Esophageal motility disorders in the rheumatic diseases: a review of 150 patients","volume":"12","author":"Lapadula G","year":"1994","unstructured":"Lapadula G, Muolo P, Semeraro F, et al.. Esophageal motility disorders in the rheumatic diseases: a review of 150 patients. Clin Exp Rheumatol. 1994, 12:515-21.","journal-title":"Clin Exp Rheumatol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1080\/03009740500339961","article-title":"Dysphagia associated with anti-PM-Scl antibodies in systemic lupus erythematosus","volume":"35","author":"Borrows R","year":"2006","unstructured":"Borrows R, Chapel H, Steuer A, Maidment G. Dysphagia associated with anti-PM-Scl antibodies in systemic lupus erythematosus. Scand J Rheumatol. 2006, 35:156-7. 10.1080\/03009740500339961","journal-title":"Scand J Rheumatol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1159\/000493390","article-title":"Rheumatoid arthritis: a brief overview of the treatment","volume":"27","author":"Bullock J","year":"2018","unstructured":"Bullock J, Rizvi SA, Saleh AM, Ahmed SS, Do DP, Ansari RA, Ahmed J. Rheumatoid arthritis: a brief overview of the treatment. Med Princ Pract. 2018, 27:501-7. 10.1159\/000493390","journal-title":"Med Princ Pract"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3109\/03009747009165356","article-title":"Studies on the sicca syndrome in patients with rheumatoid arthritis","volume":"16","author":"Ericson S","year":"1987","unstructured":"Ericson S, Sundmark E. Studies on the sicca syndrome in patients with rheumatoid arthritis. Scand J Rheumatol. 1987, 16:60-80. 10.3109\/03009747009165356","journal-title":"Scand J Rheumatol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1177\/028418518702800107","article-title":"Pharyngeal function in patients with rheumatoid arthritis of the cervical spine and temporomandibular joint","volume":"28","author":"Ekberg O","year":"1987","unstructured":"Ekberg O, Redlund-Johnell I, Sj\u00f6blom KG. Pharyngeal function in patients with rheumatoid arthritis of the cervical spine and temporomandibular joint. Acta Radiol. 1987, 28:35-9. 10.1177\/028418518702800107","journal-title":"Acta Radiol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196207262670407","article-title":"Incidence of laryngeal involvement in rheumatoid arthritis","volume":"267","author":"Lofgren RH","year":"1962","unstructured":"Lofgren RH, Montgomery WW. Incidence of laryngeal involvement in rheumatoid arthritis. N Engl J Med. 1962, 267:193-5. 10.1056\/NEJM196207262670407","journal-title":"N Engl J Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.3109\/00016489109100771","article-title":"Swallowing problems in rheumatoid arthritis","volume":"111","author":"Geterud A","year":"1991","unstructured":"Geterud A, Bake B, Bjelle A, Jonsson R, Sandberg N, Ejnell H. Swallowing problems in rheumatoid arthritis. Acta Otolaryngol. 1991, 111:1153-61. 10.3109\/00016489109100771","journal-title":"Acta Otolaryngol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2017.09.005","article-title":"Gastrointestinal and hepatic disease in rheumatoid arthritis","volume":"44","author":"Craig E","year":"2018","unstructured":"Craig E, Cappelli LC. Gastrointestinal and hepatic disease in rheumatoid arthritis. Rheum Dis Clin North Am. 2018, 44:89-111. 10.1016\/j.rdc.2017.09.005","journal-title":"Rheum Dis Clin North Am"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3109\/00365529009093155","article-title":"Upper gastrointestinal manifestations in rheumatoid arthritis patients: intrinsic or extrinsic pathogenesis?","volume":"178","author":"Janssen M","year":"1990","unstructured":"Janssen M, Dijkmans BA, Lamers CB. Upper gastrointestinal manifestations in rheumatoid arthritis patients: intrinsic or extrinsic pathogenesis?. Scand J Gastroenterol Suppl. 1990, 178:79-84. 10.3109\/00365529009093155","journal-title":"Scand J Gastroenterol Suppl"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7659273","article-title":"The videofluorographic swallowing study in rheumatologic diseases: a comprehensive review","volume":"2017","author":"Di Piazza A","year":"2017","unstructured":"Di Piazza A, Vernuccio F, Costanzo M, et al.. The videofluorographic swallowing study in rheumatologic diseases: a comprehensive review. Gastroenterol Res Pract. 2017, 2017:7659273. 10.1155\/2017\/7659273","journal-title":"Gastroenterol Res Pract"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1007\/BF01255603","article-title":"Upper gastrointestinal disease in rheumatoid arthritis","volume":"19","author":"Sun DC","year":"1974","unstructured":"Sun DC, Roth SH, Mitchell CS, Englund DW. Upper gastrointestinal disease in rheumatoid arthritis. Am J Dig Dis. 1974, 19:405-10. 10.1007\/BF01255603","journal-title":"Am J Dig Dis"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00799","article-title":"Increased risk of thyroid dysfunction among patients with rheumatoid arthritis","volume":"9","author":"Li Q","year":"2018","unstructured":"Li Q, Wang B, Mu K, et al.. Increased risk of thyroid dysfunction among patients with rheumatoid arthritis. Front Endocrinol (Lausanne). 2018, 9:799. 10.3389\/fendo.2018.00799","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1007\/s13317-016-0074-1","article-title":"Beh\u00e7et's disease physiopathology: a contemporary review","volume":"7","author":"Zeidan MJ","year":"2016","unstructured":"Zeidan MJ, Saadoun D, Garrido M, Klatzmann D, Six A, Cacoub P. Beh\u00e7et's disease physiopathology: a contemporary review. Auto Immun Highlights. 2016, 7:4. 10.1007\/s13317-016-0074-1","journal-title":"Auto Immun Highlights"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1310066","article-title":"Pharyngeal webs in a patient with dysphagia and Behcet's disease","volume":"44 Suppl 2 UCTN","author":"Efthymiou M","year":"2012","unstructured":"Efthymiou M, Raftopoulos S, Kortan P. Pharyngeal webs in a patient with dysphagia and Behcet's disease. Endoscopy. 2012, 44 Suppl 2 UCTN:E374. 10.1055\/s-0032-1310066","journal-title":"Endoscopy"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1136\/thx.26.2.155","article-title":"Dysphagia in Beh\u00e7et's syndrome","volume":"26","author":"Arma S","year":"1971","unstructured":"Arma S, Habibulla KS, Price JJ, Collis JL. Dysphagia in Beh\u00e7et's syndrome. Thorax. 1971, 26:155-8. 10.1136\/thx.26.2.155","journal-title":"Thorax"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1159\/000112645","article-title":"Manometric evaluation of the esophagus in patients with Beh\u00e7et's disease","volume":"76","author":"Bektas M","year":"2007","unstructured":"Bektas M, Altan M, Alkan M, Ormeci N, Soykan I. Manometric evaluation of the esophagus in patients with Beh\u00e7et's disease. Digestion. 2007, 76:192-5. 10.1159\/000112645","journal-title":"Digestion"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1155\/2000\/423569","article-title":"Esophageal involvement in Wegener's granulomatosis: a case report and review of the literature","volume":"14","author":"Fallows GA","year":"2000","unstructured":"Fallows GA, Hamilton SF, Taylor DS, Reddy SB. Esophageal involvement in Wegener's granulomatosis: a case report and review of the literature. Can J Gastroenterol. 2000, 14:449-51. 10.1155\/2000\/423569","journal-title":"Can J Gastroenterol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2011.04.018","article-title":"Extra-pulmonary manifestations of sarcoidosis","volume":"67","author":"Vardhanabhuti V","year":"2012","unstructured":"Vardhanabhuti V, Venkatanarasimha N, Bhatnagar G, Maviki M, Iyengar S, Adams WM, Suresh P. Extra-pulmonary manifestations of sarcoidosis. Clin Radiol. 2012, 67:263-76. 10.1016\/j.crad.2011.04.018","journal-title":"Clin Radiol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/836203","article-title":"Esophageal sarcoidosis: a review of cases and an update","volume":"2013","author":"Abraham A","year":"2013","unstructured":"Abraham A, Hajar R, Virdi R, Singh J, Mustacchia P. Esophageal sarcoidosis: a review of cases and an update. ISRN Gastroenterol. 2013, 2013:836203. 10.1155\/2013\/836203","journal-title":"ISRN Gastroenterol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.5555\/uri:pii:0039606083901605","article-title":"Achalasia of the cardia associated with pulmonary sarcoidosis","volume":"94","author":"Dufresne CR","year":"1983","unstructured":"Dufresne CR, Jeyasingham K, Baker RR. Achalasia of the cardia associated with pulmonary sarcoidosis. Surgery. 1983, 94:32-5. 10.5555\/uri:pii:0039606083901605","journal-title":"Surgery"},{"key":"ref76","article-title":"Muscle involvement in sarcoidosis: a retrospective and followup studies","volume":"33","author":"Fayad F","year":"2006","unstructured":"Fayad F, Liot\u00e9 F, Berenbaum F, Orcel P, Bardin T. Muscle involvement in sarcoidosis: a retrospective and followup studies. J Rheumatol. 2006, 33:98-103.","journal-title":"J Rheumatol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1291565","article-title":"An African American man with dysphagia: a unique initial presentation of sarcoidosis","volume":"44 Suppl 2 UCTN","author":"Samarasena JB","year":"2012","unstructured":"Samarasena JB, Chu E, Muthusamy VR. An African American man with dysphagia: a unique initial presentation of sarcoidosis. Endoscopy. 2012, 44 Suppl 2 UCTN:E63-4. 10.1055\/s-0031-1291565","journal-title":"Endoscopy"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1007\/BF02238178","article-title":"Sarcoidosis of the esophagus","volume":"16","author":"Wiesner PJ","year":"1971","unstructured":"Wiesner PJ, Kleinman MS, Condemi JJ, Resnicoff SA, Schwartz SI. Sarcoidosis of the esophagus. Am J Dig Dis. 1971, 16:943-51. 10.1007\/BF02238178","journal-title":"Am J Dig Dis"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre D","year":"2014","unstructured":"Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, M\u00fcller-Quernheim J. Sarcoidosis. Lancet. 2014, 383:1155-67. 10.1016\/s0140-6736(13)60680-7","journal-title":"Lancet"},{"key":"ref80","article-title":"Dysphagia due to granulomatous myositis of the cricopharyngeus muscle; physiological and cineradiographic studies prior to and following successful surgical therapy","volume":"74","author":"Siegel CI","year":"1961","unstructured":"Siegel CI, Honda M, Salik J, Mendeloff AI. Dysphagia due to granulomatous myositis of the cricopharyngeus muscle; physiological and cineradiographic studies prior to and following successful surgical therapy. Trans Assoc Am Physicians. 1961, 74:342-52.","journal-title":"Trans Assoc Am Physicians"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.12.289","article-title":"Esophageal motility disorders: Current approach to diagnostics and therapeutics","volume":"162","author":"Patel DA","year":"2022","unstructured":"Patel DA, Yadlapati R, Vaezi MF. Esophageal motility disorders: Current approach to diagnostics and therapeutics. Gastroenterology. 2022, 162:1617-34. 10.1053\/j.gastro.2021.12.289","journal-title":"Gastroenterology"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2013.10.009","article-title":"Dysphagia in the elderly","volume":"30","author":"Khan A","year":"2014","unstructured":"Khan A, Carmona R, Traube M. Dysphagia in the elderly. Clin Geriatr Med. 2014, 30:43-53. 10.1016\/j.cger.2013.10.009","journal-title":"Clin Geriatr Med"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2021.05.013","article-title":"Dysphagia and swallowing disorders","volume":"105","author":"McCarty EB","year":"2021","unstructured":"McCarty EB, Chao TN. Dysphagia and swallowing disorders. Med Clin North Am. 2021, 105:939-54. 10.1016\/j.mcna.2021.05.013","journal-title":"Med Clin North Am"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-8323-0_23","article-title":"Gastrointestinal Manifestations of Rheumatic Diseases","author":"Halabi H","year":"2021","unstructured":"Halabi H, AlDabbagh A, Alamoudi A. Gastrointestinal Manifestations of Rheumatic Diseases. Skills in Rheumatology. Almoallim H, Cheikh M (ed): Springer, Singapore; 2021. 475-99. 10.1007\/978-981-15-8323-0_23"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X11425092","article-title":"Diagnosis and treatment of inflammatory myopathy: issues and management","volume":"4","author":"Castro C","year":"2012","unstructured":"Castro C, Gourley M. Diagnosis and treatment of inflammatory myopathy: issues and management. Ther Adv Musculoskelet Dis. 2012, 4:111-20. 10.1177\/1759720X11425092","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200410000-00006","article-title":"Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis","volume":"17","author":"Dalakas MC","year":"2004","unstructured":"Dalakas MC. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Curr Opin Neurol. 2004, 17:561-7. 10.1097\/00019052-200410000-00006","journal-title":"Curr Opin Neurol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.2165\/11310780-000000000-00000","article-title":"Cutaneous lupus erythematosus: issues in diagnosis and treatment","volume":"10","author":"Walling HW","year":"2009","unstructured":"Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol. 2009, 10:365-81. 10.2165\/11310780-000000000-00000","journal-title":"Am J Clin Dermatol"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1546954","article-title":"Dysphagia secondary to anterior osteophytes of the cervical spine","volume":"5","author":"Egerter AC","year":"2015","unstructured":"Egerter AC, Kim ES, Lee DJ, Liu JJ, Cadena G, Panchal RR, Kim KD. Dysphagia secondary to anterior osteophytes of the cervical spine. Global Spine J. 2015, 5:e78-83. 10.1055\/s-0035-1546954","journal-title":"Global Spine J"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1007\/BF00301918","article-title":"Neurogenic dysphagia: what is the cause when the cause is not obvious?","volume":"9","author":"Buchholz DW","year":"1994","unstructured":"Buchholz DW. Neurogenic dysphagia: what is the cause when the cause is not obvious?. Dysphagia. 1994, 9:245-55. 10.1007\/BF00301918","journal-title":"Dysphagia"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-020-00950-3","article-title":"Impact and management of dysphagia in inflammatory myopathies","volume":"22","author":"Zeng R","year":"2020","unstructured":"Zeng R, Schmidt J. Impact and management of dysphagia in inflammatory myopathies. Curr Rheumatol Rep. 2020, 22:74. 10.1007\/s11926-020-00950-3","journal-title":"Curr Rheumatol Rep"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314109","article-title":"Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS)","volume":"66","author":"Beg S","year":"2017","unstructured":"Beg S, Ragunath K, Wyman A, et al.. Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS). Gut. 2017, 66:1886-99. 10.1136\/gutjnl-2017-314109","journal-title":"Gut"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.4103\/ijri.IJRI_465_18","article-title":"Barium esophagogram in various esophageal diseases: a pictorial essay","volume":"29","author":"Debi U","year":"2019","unstructured":"Debi U, Sharma M, Singh L, Sinha A. Barium esophagogram in various esophageal diseases: a pictorial essay. Indian J Radiol Imaging. 2019, 29:141-54. 10.4103\/ijri.IJRI_465_18","journal-title":"Indian J Radiol Imaging"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000734","article-title":"ACG clinical guidelines: clinical use of esophageal physiologic testing","volume":"115","author":"Gyawali CP","year":"2020","unstructured":"Gyawali CP, Carlson DA, Chen JW, Patel A, Wong RJ, Yadlapati RH. ACG clinical guidelines: clinical use of esophageal physiologic testing. Am J Gastroenterol. 2020, 115:1412-28. 10.14309\/ajg.0000000000000734","journal-title":"Am J Gastroenterol"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04190.x","article-title":"Review article: the gastrointestinal complications of myositis","volume":"31","author":"Ebert EC","year":"2010","unstructured":"Ebert EC. Review article: the gastrointestinal complications of myositis. Aliment Pharmacol Ther. 2010, 31:359-65. 10.1111\/j.1365-2036.2009.04190.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2012.02.010","article-title":"The effects of lingual intervention in a patient with inclusion body myositis and Sj\u00f6gren's syndrome: a longitudinal case study","volume":"93","author":"Malandraki GA","year":"2012","unstructured":"Malandraki GA, Kaufman A, Hind J, Ennis S, Gangnon R, Waclawik A, Robbins J. The effects of lingual intervention in a patient with inclusion body myositis and Sj\u00f6gren's syndrome: a longitudinal case study. Arch Phys Med Rehabil. 2012, 93:1469-75. 10.1016\/j.apmr.2012.02.010","journal-title":"Arch Phys Med Rehabil"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1177\/1756285608097463","article-title":"Therapeutic advances and future prospects in immune-mediated inflammatory myopathies","volume":"1","author":"Dalakas MC","year":"2008","unstructured":"Dalakas MC. Therapeutic advances and future prospects in immune-mediated inflammatory myopathies. Ther Adv Neurol Disord. 2008, 1:157-66. 10.1177\/1756285608097463","journal-title":"Ther Adv Neurol Disord"},{"key":"ref97","article-title":"Prognosis of dysphagia in dermatomyositis","volume":"37","author":"Ogawa-Momohara M","year":"2019","unstructured":"Ogawa-Momohara M, Muro Y, Kono M, Akiyama M. Prognosis of dysphagia in dermatomyositis. Clin Exp Rheumatol. 2019, 37:165.","journal-title":"Clin Exp Rheumatol"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X19886494","article-title":"New insights into the treatment of myositis","volume":"12","author":"Glaubitz S","year":"2020","unstructured":"Glaubitz S, Zeng R, Schmidt J. New insights into the treatment of myositis. Ther Adv Musculoskelet Dis. 2020, 12:1759720X19886494. 10.1177\/1759720X19886494","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20325","article-title":"Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients","volume":"62","author":"Marie I","year":"2010","unstructured":"Marie I, Menard JF, Hatron PY, et al.. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Arthritis Care Res (Hoboken). 2010, 62:1748-55. 10.1002\/acr.20325","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-0492","article-title":"IV immunoglobulin might be considered as a first-line treatment of severe interstitial lung disease associated with polymyositis","volume":"140","author":"Diot E","year":"2011","unstructured":"Diot E, Carmier D, Marquette D, Marchand-Adam S, Diot P, Lesire V. IV immunoglobulin might be considered as a first-line treatment of severe interstitial lung disease associated with polymyositis. Chest. 2011, 140:562-3. 10.1378\/chest.11-0492","journal-title":"Chest"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102757","article-title":"Real life picture of the use of intravenous immunoglobulins in idiopathic inflammatory myopathies: results of a multicentric study","volume":"20","author":"Barsotti S","year":"2021","unstructured":"Barsotti S, Cavazzana I, Zanframundo G, et al.. Real life picture of the use of intravenous immunoglobulins in idiopathic inflammatory myopathies: results of a multicentric study. Autoimmun Rev. 2021, 20:102757. 10.1016\/j.autrev.2021.102757","journal-title":"Autoimmun Rev"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa443","article-title":"Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis","volume":"60","author":"Giannini M","year":"2021","unstructured":"Giannini M, Fiorella ML, Tampoia M, et al.. Long-term efficacy of adding intravenous immunoglobulins as treatment of refractory dysphagia related to myositis: a retrospective analysis. Rheumatology (Oxford). 2021, 60:1234-42. 10.1093\/rheumatology\/keaa443","journal-title":"Rheumatology (Oxford)"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1159\/000441490","article-title":"Subcutaneous immunoglobulin use in inclusion body myositis: a review of 6 cases","volume":"7","author":"Cherin P","year":"2015","unstructured":"Cherin P, Delain JC, de Jaeger C, Crave JC. Subcutaneous immunoglobulin use in inclusion body myositis: a review of 6 cases. Case Rep Neurol. 2015, 7:227-32. 10.1159\/000441490","journal-title":"Case Rep Neurol"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.4137\/CCRep.S10200","article-title":"Balloon dilation in sporadic inclusion body myositis patients with dysphagia","volume":"6","author":"Murata KY","year":"2013","unstructured":"Murata KY, Kouda K, Tajima F, Kondo T. Balloon dilation in sporadic inclusion body myositis patients with dysphagia. Clin Med Insights Case Rep. 2013, 6:1-7. 10.4137\/CCRep.S10200","journal-title":"Clin Med Insights Case Rep"},{"key":"ref105","article-title":"Long-term follow-up of sporadic inclusion body myositis treated with intravenous immunoglobulin: a retrospective study of 16 patients","volume":"30","author":"Dobloug C","year":"2012","unstructured":"Dobloug C, Walle-Hansen R, Gran JT, Molberg \u00d8. Long-term follow-up of sporadic inclusion body myositis treated with intravenous immunoglobulin: a retrospective study of 16 patients. Clin Exp Rheumatol. 2012, 30:838-42.","journal-title":"Clin Exp Rheumatol"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102431","article-title":"Corticosteroid-sparing benefit of intravenous immunoglobulin in systemic sclerosis-associated myopathy: a comparative study in 52 patients","volume":"19","author":"Chaigne B","year":"2020","unstructured":"Chaigne B, Rodeia S, Benmostefa N, et al.. Corticosteroid-sparing benefit of intravenous immunoglobulin in systemic sclerosis-associated myopathy: a comparative study in 52 patients. Autoimmun Rev. 2020, 19:102431. 10.1016\/j.autrev.2019.102431","journal-title":"Autoimmun Rev"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102997","article-title":"Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis","volume":"21","author":"Goswami RP","year":"2022","unstructured":"Goswami RP, Haldar SN, Chatterjee M, et al.. Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis. Autoimmun Rev. 2022, 21:102997. 10.1016\/j.autrev.2021.102997","journal-title":"Autoimmun Rev"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.12.003","article-title":"Long-term subcutaneous immunoglobulin use in inflammatory myopathies: A retrospective review of 19 cases","volume":"15","author":"Cherin P","year":"2016","unstructured":"Cherin P, Belizna C, Cartry O, et al.. Long-term subcutaneous immunoglobulin use in inflammatory myopathies: A retrospective review of 19 cases. Autoimmun Rev. 2016, 15:281-286. 10.1016\/j.autrev.2015.12.003","journal-title":"Autoimmun Rev"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004303.pub4","article-title":"Interventions for dysphagia in long-term, progressive muscle disease","volume":"2","author":"Jones K","year":"2016","unstructured":"Jones K, Pitceathly RD, Rose MR, et al.. Interventions for dysphagia in long-term, progressive muscle disease. Cochrane Database Syst Rev. 2016, 2:004303. 10.1002\/14651858.CD004303.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.48.3.712","article-title":"Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study","volume":"48","author":"Dalakas MC","year":"1997","unstructured":"Dalakas MC, Sonies B, Dambrosia J, Sekul E, Cupler E, Sivakumar K. Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study. Neurology. 1997, 48:712-716. 10.1212\/wnl.48.3.712","journal-title":"Neurology"},{"key":"ref111","article-title":"Intravenous Immunoglobulin (IVIG)","author":"Arumugham VB","unstructured":"Arumugham VB, Rayi A. Intravenous Immunoglobulin (IVIG). StatPearls. Treasure Island (ed): 2022,"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1097\/PHM.0b013e31818a50e2","article-title":"Dysphagia in inclusion body myositis: clinical features, management, and clinical outcome","volume":"87","author":"Oh TH","year":"2008","unstructured":"Oh TH, Brumfield KA, Hoskin TL, Kasperbauer JL, Basford JR. Dysphagia in inclusion body myositis: clinical features, management, and clinical outcome. Am J Phys Med Rehabil. 2008, 87:883-889. 10.1097\/PHM.0b013e31818a50e2","journal-title":"Am J Phys Med Rehabil"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/141831-autoimmune-dysphagia-related-to-rheumatologic-disorders-a-focused-review-on-diagnosis-and-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:26Z","timestamp":1707509126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/141831-autoimmune-dysphagia-related-to-rheumatologic-disorders-a-focused-review-on-diagnosis-and-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":112,"URL":"https:\/\/doi.org\/10.7759\/cureus.41883","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,14]]}}}